https://www.nature.com/articles/s41467-026-72381-0
This is a very interesting paper which also looks as isoform issues (one of my particular interests because of the links to acetylation), but sadly does not look at whether isoform expression balance changes with age (which it probably does).
chatGPT:
Summary
This paper tests a central prediction of antagonistic pleiotropy: that some genes improve early-life fitness traits but impose late-life costs. The authors focus on vgll3, a gene already associated by GWAS with puberty/maturation timing in humans and Atlantic salmon. They use the short-lived turquoise killifish as a vertebrate model, because it matures rapidly and has a naturally compressed lifespan.
The key finding is that disrupting vgll3, especially the exon 1/long-isoform mutation, accelerates male growth and sexual maturation. Mutant males were larger, heavier, had higher gonadosomatic index, more germline proliferation, more mature sperm, and increased proliferating intestinal crypt cells. This suggests that reduced/altered vgll3 activity pushes the animal toward a faster growth-and-reproduction programme.
However, the same mutation produced late-life costs. Older male mutants developed melanoma-like caudal-fin expansions at much higher frequency, and these lesions were functionally validated as tumour-like because cells from them engrafted, proliferated, and invaded tissues when transplanted into newly generated rag2 immunodeficient killifish. The mutants also had shortened lifespan: about 15% lower median lifespan in males and 7% lower in females, with increased age-related mortality.
Mechanistically, the authors link the phenotype to increased cell proliferation, altered transcriptional programmes, and DNA damage response changes. Fibroblasts from exon 1 mutants showed increased EdU incorporation and higher γH2AX after etoposide, consistent with faster cycling and/or altered DNA-damage handling. In vivo, mutant testes also showed increased γH2AX staining.
The paper therefore argues that vgll3 is a causal vertebrate example of an antagonistically pleiotropic gene: reduced/altered function improves early growth and reproductive maturation but increases cancer risk and mortality later.
Novelty
The main novelty is that this is not just a correlational GWAS or comparative-genomics observation. The authors perform causal genetic perturbation of a specific life-history gene in a vertebrate and then follow the animals longitudinally across early-life and late-life phenotypes.
Specific novel contributions include:
-
A single-gene vertebrate test of antagonistic pleiotropy.
The paper links one gene, vgll3, to accelerated maturation, increased growth, higher stem/germline proliferation, increased cancer-like disease, and reduced lifespan. -
Isoform-aware manipulation of vgll3.
The authors identify long and short vgll3 isoforms, note conservation of the short isoform across vertebrates, and use exon 1 versus exon 3 mutations to distinguish effects on the long isoform versus both isoforms. -
Connection to human and salmon maturation genetics.
The paper places killifish results in the context of prior human and salmon GWAS linking VGLL3/vgll3 to puberty or age at maturity, making the finding potentially relevant beyond killifish. -
Development of a rag2 immunodeficient killifish cancer model.
This is a useful technical advance: the authors generate a rag2 mutant killifish lacking effective V(D)J recombination, enabling tumour engraftment studies in this short-lived vertebrate model. -
A growth–cancer–lifespan axis.
The paper connects faster maturation and proliferation to later melanoma-like disease and mortality, giving a coherent life-history trade-off.
Critique
The paper is strong because it combines genetics, longitudinal phenotyping, transcriptomics, cell assays, tumour transplantation, and survival analysis. The broad phenotype is internally consistent: more proliferation and earlier maturity early, more cancer and death later.
However, the interpretation as true evolutionary antagonistic pleiotropy is not fully proven. The authors themselves acknowledge that their data do not definitively exclude mutation accumulation. To prove antagonistic pleiotropy in nature, one would need evidence that naturally occurring vgll3 variants are actively maintained because their early-life fitness benefits outweigh late-life costs in real ecological settings. The paper shows causal age-opposed effects, but not the full population-genetic fitness balance.
A second limitation is that much of the strongest mechanistic work uses engineered loss-of-function mutations, not naturally occurring alleles. These mutations may not perfectly model the subtler regulatory or coding variants found in salmon, humans, or wild killifish populations. The paper would be stronger if it introduced naturally occurring vgll3 variants or swapped alleles between fast- and slow-life-history killifish populations.
Third, the mechanistic link between vgll3 and cancer remains somewhat incomplete. The authors show altered DNA-damage response and tumour engraftment, but they do not yet define whether vgll3 loss directly causes genomic instability, alters melanocyte lineage control, changes Hippo/TEAD signalling, or creates a permissive proliferative environment in which secondary mutations accumulate. They note that RNA-seq or whole-genome sequencing of mutant melanocytes would help resolve this.
Fourth, the sex-specificity is biologically plausible but leaves questions. The strongest growth, maturation, cancer, and lifespan effects are in males, aligning with salmon data and male gonadal expression. But the female lifespan effect, though smaller, suggests broader systemic effects that are not fully explored.
Finally, the tumour sample sizes are relatively small in the functional engraftment experiments, even though the results are striking. The melanoma-like phenotype is convincing as a late-life pathology, but more histological, molecular, and genomic tumour characterization would strengthen the cancer conclusion.
Bottom line
This is a high-value paper because it gives a rare causal vertebrate example of a gene that shifts the organism toward faster growth and reproduction at the apparent cost of cancer risk and shorter lifespan. The strongest claim is that vgll3 regulates a life-history trade-off. The more ambitious claim—that this proves natural antagonistic pleiotropy as the evolutionary mechanism—is plausible but not fully established without ecological fitness and natural-allele data.
second response:
Not really.
The paper does consider isoform balance, but mainly around development/puberty, not ageing.
What it does:
- It identifies a putative long and short vgll3 isoform, with the short isoform arising from an alternative 5′ UTR/start site within intron 1.
- It re-analyses adult male gonad RNA-seq and predicts that both isoforms exist in killifish testis.
- It uses qPCR on testes from prepubertal and pubertal killifish and finds a “significant predominance of the longer transcript.”
- It explicitly notes a limitation: the data cannot determine whether the isoforms are co-expressed in the same cell type or in different cells.
What it does not appear to do:
- It does not present a time course of long/short vgll3 isoform expression across ageing.
- It does not compare young, mature, and old fish for isoform ratio.
- It does not test whether the late-life cancer/lifespan phenotype is associated with an age-dependent shift in vgll3 isoform balance.
- Its ageing experiments focus on phenotype: melanoma-like expansion, tumour engraftment, survival, and mortality curves, rather than age-dependent isoform usage.
So the answer is: the paper raises isoform balance as mechanistically important, especially for maturity timing, but it does not directly test whether vgll3 isoform balance changes with age. That would be a good follow-up experiment: age-series RNA-seq or isoform-specific qPCR in testes, gonadal somatic cells, skin/melanocytes, intestine, and perhaps fibroblasts from young versus old WT and mutant fish.